Linear chart below (showing movement in pence), semilog chart above (percentage movements)
Share price has doubled since the start of 2013 - yet nobody on this BB is discussing it? Strange!
It floated on AIM at 80p less than a year ago, since when its share price has more than trebled. This week the market capitalisation has risen above the £100m level, which is a significant threshold - many funds won't buy into companies smaller than that but may now become interested in this one.
Website
www.retroscreen.com
They employ live human volunteers in tests. As decribed on website Home Page. Analysing pathways taken by respiratory diseases, allowing better targeting of treatments.
IP Group (IPO) is a significant stakeholder.
"..Retroscreen Virology has developed a business system with two principal units. The first is a Clinical Services business built around Human Viral Challenge Model and the second is a Translational Research (Pre-Clinical) business, built around in-house expertise on testing antivirals and virucidals in-vitro.
The team at Retroscreen Virology are committed to creating the next generation of drugs and vaccines for a number of respiratory diseases..."